LIMBER-TREG108: Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs (clinicaltrials.gov) - Oct 22, 2026 - P1 | N=24 | Recruiting | Sponsor: Cellenkos, Inc. | Trial completion date: Dec 2026 ➔ Dec 2027 | Trial primary completion date: Apr 2026 ➔ Apr 2027
Trial completion date • Trial primary completion date • Essential Thrombocythemia • Myelofibrosis • Neutropenia
|